Therapeutic Delivery – Products

Researchers are using chips from Dolomite Microfluidics to reliably and consistently produce monodisperse particles for targeted delivery of small interfering RNA (siRNA) therapeutics.

Under the agreement, the companies will expand their existing collaboration and jointly develop an oral formulation of a new active ingredient with an enhanced bioavailability.

Leaders in chemistry data management have combined to deliver a unified data resource for materials characterization.

Erisyon, the company that is transforming how we detect, treat, and monitor disease, has today revealed that it is the recipient of a grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF). Erisyon will use the funds to deploy the power of single molecule protein sequencing for the detection and validation of biomarkers that have the potential for early detection of the disease.

Entos Pharmaceuticals (Entos), a healthcare biotechnology company that develops next generation nucleic acid medicines using the Fusogenix drug delivery platform, today announced a collaboration with EpiVax, Inc. (EpiVax), a world leading informatics and immunology biotechnology company with a proven track record in vaccine development.

Postnova Analytics has reported that its CF2000 Centrifugal Field Flow Fractionation system is delivering exciting new data to scientists developing drug delivery systems.

BD has announced the completion of a 50-subject human clinical trial with the BD Libertas™ Wearable Injector.

MetP Pharma has announced that it has received a Notice of Allowance from the United States Patent and Trademark Office for its patent entitled “Treatment of Demyelinating Diseases”.

The 3rd Annual Postnova Analytics Field Flow Fractionation (FFF) User Meeting was recently held in Boston, MA (USA).

Iksuda Therapeutics (Iksuda), a developer of next generation Antibody Drug Conjugates (ADCs), has announced the first data on its lead ADC, IKS01.